DIT Seeks Participants for Patient Plus Research Program; Qualified Registrants to Receive Free Access to DIT's Drug Risk Detection System.Business Editors/Health & Medical Writers ROCKVILLE, Md.--(BW HealthWire)--April 27, 2000 DIT Drug Information Technologies, Inc., an international developer and supplier of healthcare technology, announced today that it is seeking participants for the Patient Plus Research Program. All qualified persons who register for the research program will receive a FREE subscription to DIT's Drug Risk Navigator (DRN DRN Dark Room Notes (band) DRN Data Release Number (Free Application for Federal Student Aid) DRN De Rerum Natura (Latin: On the Nature of Things) DRN Disaster Response Network ) Patient Plus system -- a powerful electronic medical record system for consumers that provides an easy and effective way to store medication records and medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. . Research results will help DIT and Scholz Healthcare to continue to improve the delivery and outcome of healthcare. Special interest groups for the Patient Plus Research Program include persons with conditions such as Alzheimer's Disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , Arthritis, Coronary Heart Disease coronary heart disease: see coronary artery disease. coronary heart disease or ischemic heart disease Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). , and Diabetes. In addition, persons taking related medications for such conditions are eligible for the free Patient Plus offer. The most sophisticated tool available for managing patient drug risk, DRN Patient Plus enables patients to easily perform drug interaction risk checks by specific drug, medical condition, and/or drug allergy drug allergy An immune response to a therapeutic. See Allergy. -- all through a few simple clicks on a keyboard. Designed with a simple interface that uses the concept of traffic lights, the non-medical professional is able to check and control drug interaction risks among drugs prescribed by various physicians. For example, an adult with allergies can check the possible interactions with prescription and herbal medications. Or, the parent of a child who takes Ritalin for Attention Deficit Disorder attention deficit (hyperactivity) disorder (ADD or ADHD) formerly hyperactivity Behavioral syndrome in children, whose major symptoms are inattention and distractibility, restlessness, inability to sit still, and difficulty concentrating on one thing for any (ADD) can determine whether prescription antibiotics will cause a reaction. At any time, users can also get immediate advice from a licensed clinician at DRN's online "help desk." Founded in 1996, DIT is committed to developing the most advanced tools for drug risk prevention, detection, and optimization. Through its leading-edge family of drug risk control software, DIT seeks to enhance communication between the physician, the pharmacist, and the patient -- resulting in better patient management and outcomes and a substantial reduction in system-wide healthcare costs. DIT -- a SCHOLZ Healthcare, Inc. company -- is the North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. component of SCHOLZ International Enterprises, a privately held, leading international healthcare software consortium. For additional information on DIT's Patient Plus Research Program, please contact Greta Umidi, Public Relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most Coordinator at 410/216-9447, or visit DIT's web site at www.DITonline.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion